Multitumor | PARP Inhibition in Four Common Cancers: Biology, Clinical Research Database and Therapeutic Strategy
Manage episode 236056111 series 1464352
Faculty presentations from a CME symposium held at the 2019 AACR Annual Meeting.
Faculty presentations from a CME symposium held at the 2019 AACR Annual Meeting. Featuring perspectives from Drs Emmanuel S Antonarakis, Kathleen Moore, Michael J Pishvaian and Melinda Telli.
- PARP Inhibition as a Therapeutic Strategy — Ovarian Cancer at the Vanguard — Dr Moore (00:00)
- Current and Emerging Role of PARP Inhibitors in Metastatic Breast Cancer — Dr Telli (8:45)
- Pancreatic Cancer and PARP Inhibition — What We Know and What We Don’t — Dr Pishvaian (20:45)
- DNA Repair Deficiency in Advanced Prostate Cancer and the Potential Role of PARP Inhibition — Dr Antonarakis (30:18)
2168 episodes available. A new episode about every 0 hours averaging 70 mins duration .